These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review]. Asztalos Z, Egervári L, Andrássy G, Faludi G, Frecska E. Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015 [Abstract] [Full Text] [Related]
5. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J. World J Biol Psychiatry; 2009 Mar; 10(1):70-3. PubMed ID: 19673089 [Abstract] [Full Text] [Related]
6. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature]. Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J. Encephale; 2001 Mar; 27(3):213-6. PubMed ID: 11488250 [Abstract] [Full Text] [Related]
7. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome]. Andreu Giménez L, Robert Gates J, Jover Díaz F, Pagán Acosta G, Merino Sánchez J. Rev Neurol; 2001 Mar; 34(4):399-400. PubMed ID: 12022063 [No Abstract] [Full Text] [Related]
8. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Litta A, Kansky C, Mauri M, Cassano GB, Fagiolini A, Casamassima F. J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293 [Abstract] [Full Text] [Related]